AMPYRA (Acorda Therapeutics, Inc.)
Welcome to the PulseAid listing for the AMPYRA drug offered from Acorda Therapeutics, Inc.. This Potassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Acorda Therapeutics, Inc. |
NON-PROPRIETARY NAME: | Dalfampridine |
SUBSTANCE NAME: | DALFAMPRIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Potassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-03-01 |
END MARKETING DATE: | 0000-00-00 |
AMPYRA HUMAN PRESCRIPTION DRUG Details:
Item Description | AMPYRA from Acorda Therapeutics, Inc. |
LABELER NAME: | Acorda Therapeutics, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2010-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10144-427_5a970cb6-fb01-1f85-e053-2a91aa0a4608 |
PRODUCT NDC: | 10144-427 |
APPLICATION NUMBER: | NDA022250 |
Other DALFAMPRIDINE Pharmaceutical Manufacturers / Labelers: